ELISABETH SOSA: Open Payments
NPI 1679825921 · ORANGE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,308 in 112 payments from 36 companies in 2025. Trend: 2023 $2,981 · 2024 $2,690 · 2025 $2,308
Food & beverage: $2,308
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $245 |
| Novartis Pharmaceuticals Corporation | 12 | $209 |
| Daiichi Sankyo Inc. | 13 | $175 |
| Gilead Sciences, Inc. | 6 | $140 |
| Eisai Inc. | 7 | $136 |
| Incyte Corporation | 6 | $121 |
| AstraZeneca Pharmaceuticals LP | 4 | $111 |
| Janssen Biotech, Inc. | 5 | $109 |
| Celgene Corporation | 4 | $101 |
| PFIZER INC. | 4 | $92 |
Products named: KEYTRUDA, Enhertu, Lenvima, Trodelvy, REBLOZYL, KISQALI, BRUKINSA, SARCLISA.
Industry payments across FL — which companies pay providers there.
